Pulmonary tumor with osteosarcomatous and chondrosarcomatous components: The differential diagnosis

A 72-year-old woman with underlying disease of essential hypertension, type 2 diabetes mellitus, osteoporosis, and traumatic ruptured intervertebral disc of L4/5 status post microdiscectomy presented dyspnea, general weakness, and poor intake for 2 weeks and chest tightness for 2 days. She was brought to the emergency room by her family for help. The chest X-ray revealed a large pleural effusion on the right side along with a collapse of the right middle lobe. Thoracocentesis was performed, and 1200 mL of fluid was drained. The cytology showed negative for malignancy. However, chest computed tomography (CT) revealed multiple nodules with varying sizes in the left and right lungs and thickening pleura with nodules and effusion, favoring cancer metastases [Figure 1]. Therefore, she received a biopsy of the right lung and decortication of the pleura.Figure 1: Chest computed tomography (CT) revealed multiple nodules (arrows) with varying sizes in the left and right lungs and thickening pleura with nodules (arrowheads) and effusion (asterisks). (a) A coronal view of chest CT. (b) Another coronal view of chest CTPathology showed a tumor composed of malignant spindle cells with pleomorphism and increased mitotic activity admixed with osteoid and chondrosarcomatous elements [Figure 2]. Immunohistochemical stains showed the neoplastic cells were focally positive for cytokeratin (<5%) and negative for TTF-1, p40, p63, calretinin, D2-40, PAX8, desmin, myogenin, S100, and CD34. The differential diagnoses for the morphological picture are pulmonary sarcomatoid carcinoma with mesenchymal differentiation [1], sarcomatoid mesothelioma with heterologous elements [2], metastatic metaplastic carcinoma of breast [3], metastatic carcinosarcoma from uterus [4], and primary or metastatic osteosarcoma arising from bone [5,6] [Table 1].Figure 2: Pathology showed the tumor was composed of malignant spindle cells with pleomorphism (a and b) admixed with osteoid ([c], asterisks, the eosinophilic intercellular materials) and chondrosarcomatous elements (d). (All pictures with H and E stain and in the same magnification of × 200)Table 1: The differential diagnosis for pulmonary tumor with osteosarcomatous and chondrosarcomatous componentstable [1-6]Immunohistochemical stains for pulmonary sarcomatoid carcinomas typically show expression of epithelial markers (EMA and cytokeratin), TTF-1, or p40 [1]. Sarcomatoid mesotheliomas are positive for D2-40 and podoplanin [2]. Usually, metaplastic carcinomas of the breast are triple-negative breast cancer that does not express estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2 [3]. High-molecular-weight keratins such as 34βE12, CK5/6, CK14, and CK17 are useful for identification of epithelial differentiation in metaplastic carcinomas of breast, and p63 has proven to be a diagnostic marker for metaplastic carcinoma of breast [3]. Uterine carcinosarcoma characteristically expresses PAX8 markers, although that is less frequent in the sarcomatous component than the carcinomatous component [4]. Osteosarcomas are positive for osteoblastic lineage biomarkers, including osteocalcin and osteonectin [5]. Importantly, there is a diagnostic pitfall as these tumors may also express cytokeratin and EMA [6]. A subsequent abdomen-to-pelvis CT scan revealed a bulky osteolytic tumor in the left hemipelvis (measuring up to 15.1 cm in size) with necrosis, and destroying bone and surrounding tissue [Figure 3]. The uterus was small, and there was no imaging sign of gynecological-related tumor lesion. No tumor lesion was seen over bilateral breasts on chest CT. A final diagnosis of primary osteosarcoma arising from the left hemipelvis with pulmonary and pleural metastases was made.Figure 3: Abdomen-to-pelvis computed tomography revealed a bulky osteolytic tumor mass, measuring up to 15.1 cm in size, arising from the left hemipelvis with necrosis and destruction of bone and surrounding tissue. No gynecological-related tumor lesion is seenIn conclusion, a clinicopathological correlation is essential to make an appropriate diagnosis for pulmonary tumors with osteosarcomatous and chondrosarcomatous components in addition to pathological morphology and immunohistochemical stains. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed. Data availability statement All data generated or analyzed during this study are available with rationale requestion. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

Authors

Institutions

Publication Details

Journal
Tzu Chi Medical Journal
Published
2025-04-04
DOI
https://doi.org/10.4103/tcmj.tcmj_282_24
Primary Topic
Metastasis and carcinoma case studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulmonary tumor with osteosarcomatous and chondrosarcomatous components: The differential diagnosis

Bing-Ru Chung, Pau‐Yuan Chang, Yen‐Chang Chen
Tzu Chi Medical Journal
Metastasis and carcinoma case studies
article

Pulmonary tumor with osteosarcomatous and chondrosarcomatous components: The differential diagnosis

Bing-Ru Chung, Pau‐Yuan Chang, Yen‐Chang Chen
article en

Abstract

A 72-year-old woman with underlying disease of essential hypertension, type 2 diabetes mellitus, osteoporosis, and traumatic ruptured intervertebral disc of L4/5 status post microdiscectomy presented dyspnea, general weakness, and poor intake for 2 weeks and chest tightness for 2 days. She was brought to the emergency room by her family for help. The chest X-ray revealed a large pleural effusion on the right side along with a collapse of the right middle lobe. Thoracocentesis was performed, and 1200 mL of fluid was drained. The cytology showed negative for malignancy. However, chest computed tomography (CT) revealed multiple nodules with varying sizes in the left and right lungs and thickening pleura with nodules and effusion, favoring cancer metastases [Figure 1]. Therefore, she received a biopsy of the right lung and decortication of the pleura.Figure 1: Chest computed tomography (CT) revealed multiple nodules (arrows) with varying sizes in the left and right lungs and thickening pleura with nodules (arrowheads) and effusion (asterisks). (a) A coronal view of chest CT. (b) Another coronal view of chest CTPathology showed a tumor composed of malignant spindle cells with pleomorphism and increased mitotic activity admixed with osteoid and chondrosarcomatous elements [Figure 2]. Immunohistochemical stains showed the neoplastic cells were focally positive for cytokeratin (<5%) and negative for TTF-1, p40, p63, calretinin, D2-40, PAX8, desmin, myogenin, S100, and CD34. The differential diagnoses for the morphological picture are pulmonary sarcomatoid carcinoma with mesenchymal differentiation [1], sarcomatoid mesothelioma with heterologous elements [2], metastatic metaplastic carcinoma of breast [3], metastatic carcinosarcoma from uterus [4], and primary or metastatic osteosarcoma arising from bone [5,6] [Table 1].Figure 2: Pathology showed the tumor was composed of malignant spindle cells with pleomorphism (a and b) admixed with osteoid ([c], asterisks, the eosinophilic intercellular materials) and chondrosarcomatous elements (d). (All pictures with H and E stain and in the same magnification of × 200)Table 1: The differential diagnosis for pulmonary tumor with osteosarcomatous and chondrosarcomatous componentstable [1-6]Immunohistochemical stains for pulmonary sarcomatoid carcinomas typically show expression of epithelial markers (EMA and cytokeratin), TTF-1, or p40 [1]. Sarcomatoid mesotheliomas are positive for D2-40 and podoplanin [2]. Usually, metaplastic carcinomas of the breast are triple-negative breast cancer that does not express estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2 [3]. High-molecular-weight keratins such as 34βE12, CK5/6, CK14, and CK17 are useful for identification of epithelial differentiation in metaplastic carcinomas of breast, and p63 has proven to be a diagnostic marker for metaplastic carcinoma of breast [3]. Uterine carcinosarcoma characteristically expresses PAX8 markers, although that is less frequent in the sarcomatous component than the carcinomatous component [4]. Osteosarcomas are positive for osteoblastic lineage biomarkers, including osteocalcin and osteonectin [5]. Importantly, there is a diagnostic pitfall as these tumors may also express cytokeratin and EMA [6]. A subsequent abdomen-to-pelvis CT scan revealed a bulky osteolytic tumor in the left hemipelvis (measuring up to 15.1 cm in size) with necrosis, and destroying bone and surrounding tissue [Figure 3]. The uterus was small, and there was no imaging sign of gynecological-related tumor lesion. No tumor lesion was seen over bilateral breasts on chest CT. A final diagnosis of primary osteosarcoma arising from the left hemipelvis with pulmonary and pleural metastases was made.Figure 3: Abdomen-to-pelvis computed tomography revealed a bulky osteolytic tumor mass, measuring up to 15.1 cm in size, arising from the left hemipelvis with necrosis and destruction of bone and surrounding tissue. No gynecological-related tumor lesion is seenIn conclusion, a clinicopathological correlation is essential to make an appropriate diagnosis for pulmonary tumors with osteosarcomatous and chondrosarcomatous components in addition to pathological morphology and immunohistochemical stains. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed. Data availability statement All data generated or analyzed during this study are available with rationale requestion. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

Tzu Chi Medical JournalVol. 37(3)
Tzu Chi University (TW), Tzu Chi Foundation (TW)
Openalex Percentile: Top 90%
Metastasis and carcinoma case studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.